🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

1 Capsule(s) Serving Size
60 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

11.3 mg (71% DV)
✅ Within RDA (0.8× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 11.3mg UL 35mg
Proprietary Herbal Blend
0.64 Gram(s)

Other Ingredients

certified organic Brown Rice Vegetarian Capsule

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Vegetarian Women (not pregnant or lactating) Adult Male (18-50 Years)

Product Information

📋 Directions for Use

Suggested Use Take 1 capsule, twice daily, morning and afternoon, for 2-4 months as needed.

⚠️ Warnings & Precautions

CA Residents: Warning: Cancer and reproductive harm www.P65Warnings.CA.GOV

May contain: Tree nuts (ginkgo)

Warning: Do not use if tamper proof seal is damaged or missing.

Do not use if pregnant or nursing. Consult a health care professional prior to use if you have any pre-existing medical conditions or are taking any prescription medications.

Keep out of reach of children.

🧪 Formulation Notes

Enhances desire

22 whole herbs

Non-GMO product

Vegetarian friendly

3rd party tested

Promotes sex drive Supports fast recovery

Horny goat weed & korean red ginseng

Additional Information

Crystal Star ESTD 1978

U.S. F.D.A. REG. FACILITY

Product Details

UPC / SKU 7 47889 03160 1
DSLD Entry Date 2021-02-25
Product Type Other Combinations
Form Capsule
Brand Crystal Star
DSLD ID 243867
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →